9.17 USD
▲+0.24+3.03%
盘后 9.07 +1.91%
2026-08-03
市值
$1.55B
市盈率
—
EPS
-3.14
股息率
—
52 周区间
4.16 – 11.66
成交量
1.71M
Beta
1.62
目标价
21.56
52W 低 4.1652W 高 11.66
价格走势
公司简介
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company’s preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting va...